Eph as a Target in Inflammation

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|15|2|119-128

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.15, Iss.2, 2015-06, pp. : 119-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EphA2 as a target for ovarian cancer therapy

By Landen Charles N   Kinch Michael S   Sood Anil K  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1179-1187

Informa Healthcare

Access to resources Recommend Favorite

IL-1 as a target in inflammation

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 3, 2015-01 ,pp. : 206-211

Bentham Science Publishers

Access to resources Recommend Favorite

EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 5, Iss. 3, 2005-05 ,pp. : 149-157

Bentham Science Publishers

Access to resources Recommend Favorite

Hydrogen sulfide as a therapeutic target for inflammation

By Rivers Jack R   Badiei Alireza   Bhatia Madhav  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 439-449

Informa Healthcare

Access to resources Recommend Favorite

Inflammation in Atherosclerosis: A New Therapeutic Target

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 283-295

Bentham Science Publishers

Access to resources Recommend Favorite